Serum leucine‐rich alpha‐2 glycoprotein as a predictive factor of endoscopic remission in Crohn's disease
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Gastroenterology and Hepatology"
DOI: 10.1111/jgh.15907
Abstract: The usefulness of fecal calprotectin (FC) and serum leucine‐rich alpha‐2 glycoprotein (LRG) assessing the activity of Crohn's disease (CD) remains to be fully demonstrated in Asia. The present study aimed to elucidate whether FC and… read more here.
Keywords: serum leucine; endoscopic remission; leucine rich; crohn disease ... See more keywords